UnitedHealth Group Incorporated (NYSE:UNH) saw a downside of -0.60% to $502.85 after subtracting -$3.01 on Wednesday. The 5-day average trading volume is 2,066,173 shares of the company’s common stock. It has gained $513.60 in the past week and touched a new high 3 times within the past 5 days. An average of 3,784,243 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 4,119,389.
UNH’s 1-month performance is 8.63% or $40.25 on its low of $447.18 reached on 07/13/23. The company’s shares have touched a 52-week low of $445.68 and high of $558.10, with the stock’s rally to the 52-week high happening on 04/13/23. YTD, UNH has lost -5.16% or -$28.35 and has reached a new high 3 times. However, the current price is down -9.90% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
UNH stock investors last saw insider trading activity on Jul 19.WITTY ANDREW (CEO, UHG) most recently sold 4,000 shares at $506.19 per share on Jul 19. This transaction cost the insider $2,024,760. CEO, UHG, WITTY ANDREW, sold 6,160 shares at a price of $487.49 on Apr 27. Then, on Apr 25, EVP Chief People Officer McSweeney Erin sold 761 shares at a price of $494.80 per share. This transaction amounted to $376,543.
Valuation Metrics
UNH stock has a beta of 0.66. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.35 while the price-to-book (PB) in the most recent quarter is 5.77, with the price to cash flow ratio at 27.00.
As well, the company’s long term debt to equity for the quarter ending June 29 was 0.75, while the total debt to equity was 0.87. The firm’s gross profit as reported stood at $79.62 billion against revenue of $324.16 billion.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 7.38% to $5.47 billion, while revenue of $5.61 billion was -2.5% off the previous quarter. Analysts expected UNH to announce $5.99 per share in earnings in its latest quarter, but it posted $6.14, representing a 2.50% surprise. EBITDA for the quarter stood at more than $9.08 billion. UNH stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 192.8 billion, with total debt at $65.59 billion. Shareholders hold equity totaling $926.3 million.
Let’s look briefly at UnitedHealth Group Incorporated (UNH) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 08 August was 51.82% to suggest the stock is trending Neutral, with historical volatility in this time period at 11.79%.
The stock’s 5-day moving average is $505.20, reflecting a -0.59% or -$2.97 change from its current price. UNH is currently trading +11.10% above its 20-day SMA, +6.32% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +4.22% and SMA200 by-3.66%.
Stochastic %K and %D was 47.70% and 56.92% and the average true range (ATR) pointed at 8.68. The RSI (14) points at 54.90%, while the 14-day stochastic is at 24.49% with the period’s ATR at 9.03. The stock’s 9-day MACD Oscillator is pointing at 1.16 and 0.13 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for UnitedHealth Group Incorporated (NYSE: UNH), UBS reiterated its a Neutral rating for the company but lifted their price target by $510 to $520. Analysts offering their rating for UNH stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate UNH as a “sell,”, while 4 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 3 rates the stock as overweight while 19 have offered a “buy” rating.
What is UNH’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $520.00 and a high of $650.00, with their median price target at $567.50. Looking at these predictions, the average price target given by analysts is for UnitedHealth Group Incorporated (UNH) stock is $572.75.
